True Open Access: No submission, publication or reading charges  

 eCM Home

 

Journal

Conferences

 eCM Journal Issues

 

Issues

Supplements

 About eCM Journal

 

 Scope & Info

 Submission

 Editors

 Societies & Sponsors

 Contact

 eCM Related Info

 

 Meetings

 Links

 eCM Paper notification

 

  (Info)

 eCM Site search

 
 
 


2004   Volume No 8 - pages 1-11

Title: A Review of Bioceramics and Fibrin Sealant

Authors: L. Le Guéhennec, P. Layrolle and G. Daculsi

Address: INSERM EM 9903, Research Center on Materials of Biological Interest Faculty of Dental Surgery, Place Alexis Ricordeau, 44042 Nantes Cedex, France.

E-mail: guy.daculsi@sante.univ-nantes.fr

Key Words: Bone substitutes, biphasic calcium phosphate, fibrin sealant

Publication date: September 13th 2004

Abstract: This review focuses on bone substitute composites made by mixing ceramic biomaterials with fibrin sealants. Different biomaterials such as coral, bone-derived materials, bioactive glass ceramics, and synthetic calcium phosphate have been mixed with fibrin sealant, resulting in a combination of the biological properties of the two
components. This type of association has not produced identical results in all studies. In the past for some, the addition of fibrin sealant to the biomaterial failed to produce any significant, positive effect on osteointegration, whereas others found a positive impact on bone colonization. Despite the negative biological effects reported previously, bioceramic-fibrin composites have been widely used in various types of bone surgery because they are easy to manipulate. In particular, the intra-operative preparation of these composites makes it possible to add bone growth factors or autologous osteoprogenitor cells prior to bone reconstruction. The bone growth factors and autologous osteoprogenitor cells associated with the bioceramic-fibrin composites should provide surgeons with tissue engineered grafts with enhanced osteointegrative properties. This review discusses both the advantages and disadvantages, as well as the future perspectives, of using bioceramic-fibrin composites in various clinical indications.

Article download: Pages 1-11. (PDF file)

Acrobat Reader:
 

To read this article you will need to install Adobe Acrobat Reader on your computer. Should you experience any difficulty in reading the PDF file we suggest that you save the file to your computer BEFORE opening it from Adobe Acrobat.

     
 

Last modified September 21, 2009

Publisher: AO Foundation, Davos, Switzerland